InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Hollingshead James, Former President and Chief Executive Officer. Insider active across 3 companies, notably RESMED INC. Cumulatively, 25 disclosures have been published. Breakdown: 1 buy · 8 sells. Total volume traded: €5m. History available since 21 May 2021. The latest transaction was filed on 28 April 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hollingshead James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
3,587 shares@ US$259.5219.4% of flowCommon StockSEC:0001127602-25-012804:0
1,160 shares@ US$272.277.2% of flowCommon StockSEC:0001127602-25-007870:0
2,074 shares@ US$267.0912.5% of flowCommon StockSEC:0001127602-25-007245:0
7,687 shares0Common StockSEC:0001127602-25-006859:0
36,671 shares0Common StockSEC:0001127602-25-005472:0
3,973 shares@ US$177.1915.4% of flowCommon StockSEC:0001127602-24-017652:0
12,303 shares0Common StockSEC:0001127602-24-007622:0
5,550 shares@ US$181.4122.1% of flowCommon StockSEC:0001127602-23-023341:0
Canonical exit: 26 Nov 2023 (T+90)
3,898 shares@ US$272.4823.4% of flowCommon StockSEC:0001127602-23-017516:0
6,875 shares0Common StockSEC:0001127602-23-007982:0
21,699 shares0Common StockSEC:0001127602-22-016388:0
2,400 shares@ US$256.845.7% of flowResMed Common StockSEC:0001127602-21-029962:0
20,360 shares@ US$254.8147.5% of flowResMed Common StockSEC:0001127602-21-029558:0
4,100 shares@ US$259.479.6% of flowResMed Common StockSEC:0001127602-21-029096:0
2,400 shares@ US$264.3465.7% of flowResMed Common StockSEC:0001127602-21-028014:0
5,741 shares0ResMed Common StockSEC:0001127602-21-026982:0
234 shares@ US$246.520.5% of flowResMed Common StockSEC:0001127602-21-026983:0
2,400 shares@ US$261.32635.6% of flowResMed Common StockSEC:0001127602-21-026355:0
2,400 shares@ US$287.30296.1% of flowResMed Common StockSEC:0001127602-21-024743:0
5,741 shares0ResMed Common StockSEC:0001127602-21-024089:0
2,400 shares@ US$268.94325.7% of flowResMed Common StockSEC:0001127602-21-022817:0
2,400 shares@ US$247.29715.2% of flowResMed Common StockSEC:0001127602-21-021468:0
2,400 shares@ US$206.03144.2% of flowResMed Common StockSEC:0001127602-21-018674:0
808 shares0Common StockSEC:0001127602-21-018304:0
2,400 shares@ US$202.014.1% of flowResMed Common StockSEC:0001127602-21-017859:0
25 of 25 declarations
About Hollingshead James
Hollingshead James is a former President and Chief Executive Officer. He has 25 filings in total, and in the recent filings observed between 2021-05-24 and 2025-04-30, buy amounts are EUR 930045 and sell amounts are EUR 4063077, with attribution filings related to RESMED INC and INSULET CORP.
